4.5 Article

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers

Journal

JOURNAL OF MEDICAL GENETICS
Volume 48, Issue 1, Pages 64-68

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jmg.2010.079814

Keywords

-

Funding

  1. NHMRC [145684, 288704, 454508]
  2. National Cancer Institute, National Institutes of Healt [RFA-CA-06-503]
  3. Cancer Care Ontario [U01 CA69467]
  4. Columbia University [U01 CA69398]
  5. Fox Chase Cancer Center [U01 CA69631]
  6. Northern California Cancer Center [U01 CA69417]
  7. University of Melbourne [U01 CA69638]
  8. Research Triangle Institute Informatics Support Center [N02PC45022-46]
  9. National Breast Cancer Foundation
  10. National Health and Medical Research Council
  11. Queensland Cancer Fund
  12. Cancer Councils of New South Wales, Victoria, Tasmania and South Australia
  13. Cancer Foundation of Western Australia
  14. Breast Cancer Research Foundation
  15. Canadian Cancer Society [18381]
  16. Dana Farber/Harvard Cancer Center Breast SPORE (NIH/NCI) [P50-CA89393]
  17. University of British Columbia
  18. Cancer Institute NSW
  19. Charles A. King Trust
  20. Bank of America
  21. Co-Trustee (Boston, MA)
  22. Humane Society
  23. Harvard Catalyst
  24. Harvard Clinical and Translational Science Center [UL1 RR 025758]
  25. Harvard University
  26. NATIONAL CANCER INSTITUTE [P50CA089393, U01CA069631, U01CA069467, U01CA069638, U01CA069417, U01CA069398] Funding Source: NIH RePORTER
  27. NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Background Germline mutations in CDH1 are associated with hereditary diffuse gastric cancer; lobular breast cancer also occurs excessively in families with such condition. Method To determine if CDH1 is a susceptibility gene for lobular breast cancer in women without a family history of diffuse gastric cancer, germline DNA was analysed for the presence of CDH1 mutations in 318 women with lobular breast cancer who were diagnosed before the age of 45 years or had a family history of breast cancer and were not known, or known not, to be carriers of germline mutations in BRCA1 or BRCA2. Cases were ascertained through breast cancer registries and high-risk cancer genetic clinics (Breast Cancer Family Registry, the kConFab and a consortium of breast cancer genetics clinics in the United States and Spain). Additionally, Multiplex Ligation-dependent Probe Amplification was performed for 134 cases to detect large deletions. Results No truncating mutations and no large deletions were detected. Six non-synonymous variants were found in seven families. Four (4/318 or 1.3%) are considered to be potentially pathogenic through in vitro and in silico analysis. Conclusion Potentially pathogenic germline CDH1 mutations in women with early-onset or familial lobular breast cancer are at most infrequent.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available